181 related articles for article (PubMed ID: 8803528)
1. Plasma and skin suction-blister-fluid pharmacokinetics and time course of the effects of oral mizolastine.
Chosidow O; Dubruc C; Danjou P; Fuseau E; Espagne E; Bianchetti G; Thenot JP; Herson S; Rosenzweig P; Revuz J
Eur J Clin Pharmacol; 1996; 50(4):327-33. PubMed ID: 8803528
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
Deschamps C; Dubruc C; Mentre F; Rosenzweig P
Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacokinetics of mizolastine.
Lebrun-Vignes B; Diquet B; Chosidow O
Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of histamine-induced skin wheal and flare after 5 days of mizolastine.
Pinquier JL; Caplain H; Cabanis MJ; Dubruc C; Stalla-Bourdillon A; Rosenzweig P
J Clin Pharmacol; 1996 Jan; 36(1):72-8. PubMed ID: 8932546
[TBL] [Abstract][Full Text] [Related]
5. Mizolastine: antihistaminic activity from preclinical data to clinical evaluation.
Simons FE
Clin Exp Allergy; 1999 Mar; 29 Suppl 1():3-8. PubMed ID: 10209699
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics and pharmacokinetics of mizolastine (SL 85.0324), a new nonsedative H1 antihistamine.
Rosenzweig P; Thebault JJ; Caplain H; Dubruc C; Bianchetti G; Fuseau E; Morselli PL
Ann Allergy; 1992 Aug; 69(2):135-9. PubMed ID: 1354949
[TBL] [Abstract][Full Text] [Related]
7. Comparative activity of cetirizine and mizolastine on histamine-induced skin wheal and flare responses at 24 h.
Purohit A; Mélac M; Pauli G; Frossard N
Br J Clin Pharmacol; 2002 Mar; 53(3):250-4. PubMed ID: 11874388
[TBL] [Abstract][Full Text] [Related]
8. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ
Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
[TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine.
Michel L; Murrieta-Aguttes M; Jean-Louis F; Levy D; Dubertret L
Ann Allergy Asthma Immunol; 2000 Jul; 85(1):64-9. PubMed ID: 10923607
[TBL] [Abstract][Full Text] [Related]
10. Lack of subsensitivity to mizolastine over 8-week treatment.
Bousquet J; Chanal I; Murrieta M; Stalla-Bourdillon A
Allergy; 1996 Apr; 51(4):251-6. PubMed ID: 8792922
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effect of bilastine.
Jauregizar N; de la Fuente L; Lucero ML; Sologuren A; Leal N; Rodríguez M
Clin Pharmacokinet; 2009; 48(8):543-54. PubMed ID: 19705924
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects.
Grant JA; Riethuisen JM; Moulaert B; DeVos C
Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924
[TBL] [Abstract][Full Text] [Related]
13. [Skin penetration of sulfamethoxazole and trimethoprim after oral administration].
Królicki A
Ann Acad Med Stetin; 2002; 48():59-73. PubMed ID: 14601469
[TBL] [Abstract][Full Text] [Related]
14. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
Wang RQ; Zhang HY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ibuprofen enantiomers in plasma and suction blister fluid in healthy volunteers.
Walker JS; Knihinicki RD; Seideman P; Day RO
J Pharm Sci; 1993 Aug; 82(8):787-90. PubMed ID: 8377114
[TBL] [Abstract][Full Text] [Related]
16. Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers.
Patat A; Perault MC; Vandel B; Ulliac N; Zieleniuk I; Rosenzweig P
Br J Clin Pharmacol; 1995 Jan; 39(1):31-8. PubMed ID: 7756096
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers.
Boyle J; Ridout F; Meadows R; Johnsen S; Hindmarch I
Curr Med Res Opin; 2005 Sep; 21(9):1495-503. PubMed ID: 16197669
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans.
Molimard M; Diquet B; Benedetti MS
Fundam Clin Pharmacol; 2004 Aug; 18(4):399-411. PubMed ID: 15312146
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic analysis of mizolastine in healthy young volunteers after single oral and intravenous doses: noncompartmental approach and compartmental modeling.
Mesnil F; Dubruc C; Mentre F; Huet S; Mallet A; Thenot JP
J Pharmacokinet Biopharm; 1997 Apr; 25(2):125-47. PubMed ID: 9408856
[TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizine.
Urien S; Tillement JP; Ganem B; Kuch MD
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):499-502. PubMed ID: 10543317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
